|
市場調查報告書
美國的診斷市場上創新的技術與其影響
Innovative Technologies And Their Impact on the US Diagnostics Market
|
美國的診斷市場上創新的技術與其影響 是由出版商Venture Planning Group在2012年01月所出版的。
這份英文市場調查報告書價格從美金4850起跳。
本報告提供美國的體外診斷(IVD)市場相關調查分析，今後10年的最重要的技術開發與其影響相關資料，主要的檢驗地方(醫院，民間的檢驗設施，診療所，血液中心，POC網站)和檢驗領域(血液銀行，臨床化學，免疫診斷學，血液凝固，血液學，流式細胞技術，組織學，細胞學，微生物學，血清學，尿液檢查)相關驗證，為您概述為以下內容。
第1章 摘要整理
第2章 結論與建議
第3章 商務環境
- 政治/法規環境
- R&D的資金提供
- 產業和政府的關係
- 產業和大學的風險企業
- 技術環境
- 分散化
- 醫療費
- 醫生的人口
- 醫院的指標
第4章 體外診斷(IVD)市場預測
- 概要
- 分子診斷
- 單株抗體
- 免疫測量
- 資訊科技/資訊
- 研究室自動化(LA)和機器人技術
- in vitro和in vivo的整合
- 體外·體內診斷的整合
- 固相化學
- 微陣列與生物晶片
- 藥理基因學
- 醫藥品
第5章 策略性影響
- 檢驗形態
- 住院前檢驗
- 住院患者的檢驗
- 門診病人的檢驗
- 檢驗數量與市場規模
- 市場區隔
- 臨床化學與免疫診斷
- 微生物學與血清學
- 血液學與流式細胞技術
- 血液銀行
- 組織學與細胞學
- 血液凝固
- 尿液檢查
- 新市場
- 購買的影響
- 行銷策略
- 合資企業，合併，許可證活動
- 進出口
- 潛在的市場進入者
- 不能存活的有誰
圖表
Abstract
The next ten years will be marked by significant technological developments in
health care and biotechnology, which will drastically change the assumptions
and perceptions of life and death. This report is designed to assist
diagnostics industry executives in exploring the impact of possible
technological developments and commercialization of a number of new products,
and formulating policy alternatives that will provide the best choice among
possible courses of action.
This invaluable strategic planning resource is designed to help corporate,
marketing and R&D executives develop effective business plans that best
accommodate uncertainties ahead.
The report:
- Evaluates emerging technologies that may present unexpected threats or
offer opportunities
- Identifies key strategic decisions that will have to be made in the future
- Enhances corporate ability to develop realistic contingency plans.
The report explores the impact of the most significant technological
developments of the next ten years and their impact on the U.S. in vitro
diagnostics market, including major testing locations (hospitals, commercial
labs, physician offices, blood centers, POC sites), and laboratory disciplines
(blood banking, clinical chemistry, immunodiagnostics, coagulation,
hematology, flow cytometry, histology, cytology, microbiology, serology,
urinalysis).
Contains 85 pages and 8 tables
Table of Contents
I. Executive Summary
2. Conclusions and Recommendations
3. Business Environment
- a. Political/Regulatory Climate
- b. R & D Funding
- c. Industry-Government Relationship
- d. Industry-University Ventures
- e. Technological Environment
- f. Decentralization
- g. Health Care Expenditures
- h. Physician Population
- i. Hospital Indicators
4. Outlook for the In Vitro Diagnostics Market
- a. Overview
- b. Molecular Diagnostics
- c. Monoclonal Antibodies
- d. Immunoassays
- e. Information Technology/Informatics
- f. Laboratory Automation and Robotics
- g. In Vitro-In Vivo Integration
- h. Solid Phase Chemistry
- i. Microarrays And Biochips
- k. Pharmacogenomics
- l. Pharmaceuticals
5. Strategic Implications
- a. Testing Patterns
- Pre-Admission Testing
- Inpatient Testing
- Outpatient Testing
- Test Volume and Market Size
- b. Market Segments
- Chemistry and Immunoassay
- Microbiology and Serology
- Hematology and Flow Cytometry
- Blood Banking
- Histology and Cytology
- Coagulation
- Urinalysis
- c. The New Marketplace
- Purchasing Influences
- Marketing Strategies
- Joint Venture, Merger, and Licensing Activity
- Import-Export
- Potential Market Entrants
- Who May Not Survive?
List of Tables
- Executive Summary
- Table: Growth Areas in Clinical Laboratory Testing
- Table-1: Total Population And Physician Demographics
- Table-2: Selected Hospital Statistics
- Table-3: Test Volume By Location
- Table-4: Test Distribution By Location
- Table-5: Market Size By Location
- Table-6: Test Volume By Laboratory Discipline
- Table-7: Market Size By Laboratory Discipline
|
